tirzepatide weight loss trials Outperforms Semaglutide in Study | Truveta posted on the topic Tirzepatide tops semaglutide for patient

Semaglutida 2,4mg sc demostr una prdida de masa grasa y masa magra total del 19,3 y 9,7%, respectivamente, a las 68 semanas en un subestudio exploratorio del STEP-129, y tirzepatida demostr una reduccin de la masa grasa y masa magra total del 33,9 y del 10,9% a las 72 semanas de tratamiento en el estudio SURMOUNT-125

Lowden says

Administered as a once-weekly subcutaneous injection, it works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying

Current mechanistic understanding emphasizes membrane fluidization and surfactant effects as primary mechanisms at the 180500 mg doses used in tablet formulations, rather than tight junction modulation as previously emphasized (Maher et al., 2009